Researcher in the lab, preparing the vaccine for use in the nebulizer. Photographer: Georgia Kirkos

Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern

Posted on

Human trials are set to begin for two next-generation COVID-19 vaccines developed by a team of scientists at McMaster University.

Both are designed to combat variants of concern and will be delivered by inhaled aerosol, not by injection, and will target the lungs and upper airways, where respiratory infections begin.

These are two of the very few COVID-19 vaccines being developed in Canada. Phase 1 of the clinical trials was recently approved by Health Canada….

https://brighterworld.mcmaster.ca/articles/researchers-to-begin-human-trials-for-promising-new-inhaled-covid-19-vaccines-designed-to-combat-variants-of-concern/

Read More Impact Stories

Posted on

B.C. researchers identify gene that fuels aggressive childhood cancers

For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Read more
Posted on

Researchers develop first COVID-19 rapid test for wastewater

McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Read more
Posted on

World’s most comprehensive study on COVID-19 mental health

Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]
Read more
View All Impact Stories